Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377611 · ClinicalTrials.gov registry record · Phase 4
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,054
- Enrollment target
NCT00377611: Completed Phase 4 study, sponsored by GlaxoSmithKline.
NCT00377611 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 3,054 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (490% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00377611, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,054 participants
- Enrollment target
Study Summary
A study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™
Primary Outcome
Analysis included all non-confirmed or lab confirmed ILI episodes (at least 1 episode, 1 episode, 2 episodes or more than (\>) 2 episodes) reported.
Interventions
- BIOLOGICAL Fluarix™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,054 participants |
| Start Date | 2006-10-05 |
| Est. Completion | 2007-06-20 |
| Phase | Phase 4 |
What the finished NCT00377611 record still lists
NCT00377611 is an interventional study that assigns participants to a tested intervention. Its 3,054 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (490% higher).
The record links to 0 conditions, and to 1 intervention - of which Fluarix™ is the first listed.
NCT00377611 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00377611 about?
NCT00377611 is a clinical study titled "Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™". A study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™
What is the current status of trial NCT00377611?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,054 participants. The study started on 2006-10-05. Estimated completion is 2007-06-20.
What interventions are being tested in trial NCT00377611?
The interventions under investigation include: Fluarix™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT00377611?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00377611's enrollment target sits among peer trials
3,054 25th of 2000 higher than 1,976 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI